BIOMAT Database Logo BIOMAT Database Logo

Antigens of Mycobacterium leprae in urine during treatment of patients with lepromatous leprosy. 1986

P Olcén, and M Harboe, and T Warndorff van Diepen

UI MeSH Term Description Entries
D007917 Leprostatic Agents Substances that suppress Mycobacterium leprae, ameliorate the clinical manifestations of leprosy, and/or reduce the incidence and severity of leprous reactions. Antileprotic Agents,Leprostatics,Agents, Antileprotic,Agents, Leprostatic
D007918 Leprosy A chronic granulomatous infection caused by MYCOBACTERIUM LEPRAE. The granulomatous lesions are manifested in the skin, the mucous membranes, and the peripheral nerves. Two polar or principal types are lepromatous and tuberculoid. Hansen's Disease,Hansen Disease
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009166 Mycobacterium leprae A species of gram-positive, aerobic bacteria that causes LEPROSY in man. Its organisms are generally arranged in clumps, rounded masses, or in groups of bacilli side by side.
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

P Olcén, and M Harboe, and T Warndorff van Diepen
Recognition of Mycobacterium leprae antigens with antibodies present in sera from patients with lepromatous leprosy.
June 1993, International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association,
P Olcén, and M Harboe, and T Warndorff van Diepen
The death rate of Mycobacterium leprae during treatment of lepromatous leprosy with acedapsone (DADDS).
July 1972, The American journal of tropical medicine and hygiene,
P Olcén, and M Harboe, and T Warndorff van Diepen
Discharge of Mycobacterium leprae from the mouth in lepromatous leprosy patients.
March 1979, Leprosy review,
P Olcén, and M Harboe, and T Warndorff van Diepen
Fate of Mycobacterium leprae in macrophages of patients with lepromatous or tuberculoid leprosy.
January 1970, International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association,
P Olcén, and M Harboe, and T Warndorff van Diepen
Screening of drug resistant strains of Mycobacterium leprae in lepromatous leprosy patients under multidrug treatment.
February 1988, The Indian journal of medical research,
P Olcén, and M Harboe, and T Warndorff van Diepen
Ulcerating lepromatous leprosy in a patient with dapsone-resistant Mycobacterium leprae.
June 1973, Leprosy review,
P Olcén, and M Harboe, and T Warndorff van Diepen
Presence of Mycobacterium leprae-reactive lymphocytes in lymph nodes of lepromatous leprosy patients.
August 1988, Scandinavian journal of immunology,
P Olcén, and M Harboe, and T Warndorff van Diepen
Mycobacterium leprae in untreated lepromatous leprosy: more than skin deep.
May 2006, Clinical and experimental dermatology,
P Olcén, and M Harboe, and T Warndorff van Diepen
Reduced suppressor cell response to Mycobacterium leprae in lepromatous leprosy.
March 1989, Infection and immunity,
P Olcén, and M Harboe, and T Warndorff van Diepen
Mechanisms of Mycobacterium leprae-specific T-cell deficiency in lepromatous leprosy.
August 1988, Biochimie,
Copied contents to your clipboard!